2019
[용어속성] Term
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
혈청학적 분석, 회복된 COVID-19 환자에서 매우 가변적인 SARS-CoV-2 중화 항체 활성 추정
Immunoassays
[키워드] 2019
Abbott
Abbott SARS-CoV-2 IgG
Accuracy
activity
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
anti-SARS-CoV-2
antibody
antiviral activity
center
choice
collected
convalescent plasma
convalescent plasma samples
coronavirus
coronavirus disease
correlated
COVID-19
Critical
determine
Donor
ELISA
ELISAs
enrolled
enzyme
enzyme-linked immunosorbent assay
enzyme-linked immunosorbent assays
estimate
gold
gold standard
house
IgG
Immunity
immunoglobin
Infection
Interpretation
levels of antibodies
levels of antibody
methodology
NAb
NAb activity
NAb assay
NAb assays
NAbs
neutralization
Neutralizing antibodies
neutralizing antibody
New York
offer
pandemic
Particles
patient sera
Population
population immunity
predict
Program
proportion
Pseudotyped virus
recovered
reopening
respiratory
SARS-CoV-2
SARS-CoV-2 detection
Sensitivity and specificity
serologic tests
Serological assay
serological assays
serological measurement
serological measurements
serological test
Serological tests
serology
Seroprevalence
severe acute respiratory syndrome Coronavirus
therapeutic
therapeutic trials
total Ig
Trial
unique
vaccination
variable
Variation
Viral
viral infection
[DOI] 10.1128/JCM.02005-20 PMC 바로가기 [Article Type] Immunoassays
[DOI] 10.1128/JCM.02005-20 PMC 바로가기 [Article Type] Immunoassays
COVID-19 in cancer patients: risk, clinical features, and management
암 환자의 COVID-19: 위험, 임상 특징 및 관리
Review
[키워드] 2019
acute respiratory syndrome
acute respiratory syndrome coronavirus
anti-cancer treatment
Anti-viral therapy
anticancer
biochemical
Cancer
cancer patient
Cancer patients
caused
Characteristics
clinical and biochemical characteristics
clinical care
Clinical features
Clinical management
coronavirus
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infections
Effect
effort
Health Organization
immunosuppressive
Immunotherapy
Inflammation
International
management
Novel coronavirus
outcome
Pathogenesis
Patient
patients
profiles
public health emergency
Research
respiratory
risk
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe COVID-19 symptoms
Spread
stimulate
therapy
Treatment
Treatment outcome
Tumor
tumor growth
vulnerable population
with COVID-19
World Health Organization
[DOI] 10.20892/j.issn.2095-3941.2020.0289 PMC 바로가기 [Article Type] Review
[DOI] 10.20892/j.issn.2095-3941.2020.0289 PMC 바로가기 [Article Type] Review
Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
인간 코로나바이러스를 전염시키는 눈의 역할: 우리가 알고 있는 것과 모르는 것
Review
[키워드] 2019
2019 novel coronavirus
2019-nCoV
2019-nCoV infection
acute respiratory syndrome
acute respiratory syndrome coronavirus
Clinical characteristics
Conjunctiva
Conjunctival secretion
Conjunctival secretions
conjunctivitis
Contact
coronavirus
CoV
CoV infection
CoVs
droplet
droplets
entry receptor
Epidemiology
eye
Genomics
Health
Health care
Health care worker
health care workers
Human
human CoV
human CoVs
hygiene
infecting
Infection
infection control
information
involved
lacrimal duct
Manifestations
mechanism
MERS
MERS-CoV
Middle East
Middle East respiratory syndrome Coronavirus
morphology
mucosa
nasal
nasolacrimal duct
nasopharyngeal
nCoV
Novel coronavirus
Ocular surface
ophthalmic
organ
outbreak
pathogen
Pathogens
Patient
PCR test
positive rate
recommendation
required
respiratory
respiratory syndrome coronavirus
respiratory tract
respiratory tract infection
respiratory viruses
RNA
role
RT-PCR test
SARS-CoV
SARS-CoV infection
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
tears
Transmission
transported
upper respiratory tract
Viral
Viral transmission
[DOI] 10.3389/fpubh.2020.00155 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fpubh.2020.00155 PMC 바로가기 [Article Type] Review